日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

A Phase III Study to Compare the Efficacy and Safety of Paclitaxel Versus Irinotecan in Patients with Metastatic or Recurrent Gastric Cancer Who Failed in First-line Therapy (KCSG ST10-01)

一项比较紫杉醇与伊立替康治疗一线治疗失败的转移性或复发性胃癌患者的疗效和安全性的 III 期研究 (KCSG ST10-01)

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2018-0142
Lee, Keun-Wook; Maeng, Chi Hoon; Kim, Tae-You; Zang, Dae Young; Kim, Yeul Hong; Hwang, In Gyu; Oh, Sang Cheul; Chung, Joo Seop; Song, Hong Suk; Kim, Jin Won; Jeong, Su Jin; Cho, Jae Yong
胃癌
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer

韩国晚期胃癌患者一线姑息化疗期间的治疗模式及生活质量变化

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2018.073
Kim, Jin Won; Kim, Jong Gwang; Kang, Byung Woog; Chung, Ik-Joo; Hong, Young Seon; Kim, Tae-You; Song, Hong Suk; Lee, Kyung Hee; Zang, Dae Young; Ko, Yoon Ho; Song, Eun-Kee; Baek, Jin Ho; Koo, Dong-Hoe; Oh, So Yeon; Cho, Hana; Lee, Keun-Wook
胃癌
肿瘤
肿瘤免疫
发表日期：2019
文献求助 收藏

Phase II Study of Dovitinib in Patients with Castration-Resistant Prostate Cancer (KCSG-GU11-05)

多维替尼治疗去势抵抗性前列腺癌患者的 II 期研究 (KCSG-GU11-05)

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2017.438
Choi, Yoon Ji; Kim, Hye Sook; Park, Se Hoon; Kim, Bong-Seog; Kim, Kyoung Ha; Lee, Hyo Jin; Song, Hong Suk; Shin, Dong-Yeop; Lee, Ha Young; Kim, Hoon-Gu; Lee, Kyung Hee; Lee, Jae Lyun; Park, Kyong Hwa
肿瘤
前列腺癌
肿瘤免疫
发表日期：2018
文献求助 收藏

An Open-Label, Randomized, Parallel, Phase III Trial Evaluating the Efficacy and Safety of Polymeric Micelle-Formulated Paclitaxel Compared to Conventional Cremophor EL-Based Paclitaxel for Recurrent or Metastatic HER2-Negative Breast Cancer

一项开放标签、随机、平行设计的III期临床试验，旨在评估聚合物胶束制剂紫杉醇与传统聚氧乙烯蓖麻油包水紫杉醇治疗复发性或转移性HER2阴性乳腺癌的疗效和安全性。

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2016.289
Park, In Hae; Sohn, Joo Hyuk; Kim, Sung Bae; Lee, Keun Seok; Chung, Joo Seop; Lee, Soo Hyeon; Kim, Tae You; Jung, Kyung Hae; Cho, Eun Kyung; Kim, Yang Soo; Song, Hong Suk; Seo, Jae Hong; Ryoo, Hun Mo; Lee, Sun Ah; Yoon, So Young; Kim, Chul Soo; Kim, Yong Tai; Kim, Si Young; Jin, Mi Ryung; Ro, Jungsil
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2017
文献求助 收藏

Targeted therapy of ovarian cancer including immune check point inhibitor

卵巢癌靶向治疗，包括免疫检查点抑制剂

期刊:Korean Journal of Internal Medicine
影响因子:2.4
doi:10.3904/kjim.2017.008
Kim, Jin Young; Cho, Chi Heum; Song, Hong Suk
肿瘤
免疫/内分泌
肿瘤免疫
卵巢癌
发表日期：2017
文献求助 收藏

Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer

转移性乳腺癌患者血浆中用于检测口服抗血管生成药物TSU-68的循环生物标志物

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2015.089
Yoo, Changhoon; Kim, Sung-Bae; Ro, Jungsil; Im, Seock-Ah; Im, Young-Hyuck; Kim, Jee Hyun; Ahn, Jin-Hee; Jung, Kyung Hae; Song, Hong Suk; Kang, Seok Yun; Park, Hee Sook; Chung, Hyun-Cheol
血管生成
肿瘤
肿瘤免疫
乳腺癌
发表日期：2016
文献求助 收藏

Metachronous double primary cancer after treatment of breast cancer

乳腺癌治疗后发生异时性双原发癌

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2013.215
Kim, Jin Young; Song, Hong Suk
肿瘤
肿瘤免疫
乳腺癌
发表日期：2015
文献求助 收藏

A phase II study of ifosfamide, methotrexate, etoposide, and prednisolone for previously untreated stage I/II extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial of the Korean Cancer Study Group

一项针对既往未接受治疗的I/II期结外自然杀伤/T细胞淋巴瘤（鼻型）的II期临床研究：异环磷酰胺、甲氨蝶呤、依托泊苷和泼尼松龙联合治疗方案的疗效评估——韩国癌症研究组的多中心试验

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2014-0305
Kim, Tae Min; Kim, Dong-Wan; Kang, Yoon-Koo; Chung, Jooseop; Song, Hong-Suk; Kim, Hyo Jung; Kim, Byung Soo; Lee, Jong-Seok; Kim, Hawk; Yang, Sung Hyun; Yuh, Young Jin; Bae, Sung Hwa; Hyun, Myung Soo; Jeon, Yoon Kyung; Kim, Chul Woo; Heo, Dae Seog
肿瘤
T细胞
肿瘤免疫
淋巴瘤
T细胞
细胞生物学
免疫/内分泌
发表日期：2014
文献求助 收藏

A Randomized Double-Blind, Double-Dummy, Multicenter Trial of Azasetron versus Ondansetron to Evaluate Efficacy and Safety in the Prevention of Delayed Nausea and Vomiting Induced by Chemotherapy

一项随机、双盲、双模拟、多中心试验，比较阿扎司琼与昂丹司琼在预防化疗引起的迟发性恶心呕吐方面的疗效和安全性

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2014.46.1.19
Lee, Hee Yeon; Kim, Hoon-Kyo; Lee, Kyung Hee; Kim, Bong-Seog; Song, Hong Suk; Yang, Sung Hyun; Kim, Joon Hee; Kim, Yeul Hong; Kim, Jong Gwang; Kim, Sang-We; Kim, Dong-Wan; Kim, Si-Young; Park, Hee Sook
发表日期：2014
文献求助 收藏

Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement

利妥昔单抗联合化疗（RCHOP）治疗伴骨髓受累的弥漫性大B细胞淋巴瘤患者的临床结果

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2013.45.2.112
Kang, Byung Woog; Moon, Joon Ho; Chae, Yee Soo; Lee, Soo Jung; Kim, Jong Gwang; Kim, Yeo-Kyeoung; Lee, Je-Jung; Yang, Deok-Hwan; Kim, Hyeoung-Joon; Kim, Jin Young; Do, Young Rok; Park, Keon Uk; Song, Hong Suk; Kwon, Ki Young; Kim, Min Kyung; Lee, Kyung Hee; Hyun, Myung Soo; Ryoo, Hun Mo; Bae, Sung Hwa; Kim, Hwak; Sohn, Sang Kyun
B细胞
HOP
淋巴瘤
CHOP
细胞生物学
免疫/内分泌
发表日期：2013
文献求助 收藏